<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Promote the Progress &#187; mental process</title>
	<atom:link href="http://promotetheprogress.com/tag/mental-process/feed/" rel="self" type="application/rss+xml" />
	<link>http://promotetheprogress.com</link>
	<description>Informed and insightful analysis of patent law issues</description>
	<lastBuildDate>Tue, 29 Dec 2009 14:17:40 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.9.2</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>After Bilski &#8211; what about mental process claims that include a known, non-mental step?</title>
		<link>http://promotetheprogress.com/after-bilski-what-about-mental-process-claims-that-include-a-known-non-mental-step/854/</link>
		<comments>http://promotetheprogress.com/after-bilski-what-about-mental-process-claims-that-include-a-known-non-mental-step/854/#comments</comments>
		<pubDate>Fri, 02 Jan 2009 12:00:23 +0000</pubDate>
		<dc:creator>J. Matt Buchanan</dc:creator>
				<category><![CDATA[Courts]]></category>
		<category><![CDATA[caselaw]]></category>
		<category><![CDATA[Bilski]]></category>
		<category><![CDATA[mental process]]></category>
		<category><![CDATA[method]]></category>
		<category><![CDATA[patentability]]></category>

		<guid isPermaLink="false">http://promotetheprogress.com/blog/?p=854</guid>
		<description><![CDATA[One paragraph opinions from the Court of Appeals for the Federal Circuit are, generally speaking, not all that interesting. The court's opinion in Classen Immunotherapies v. Biogen IDEC, decided the week before Christmas, breaks this general rule, though.  The one paragraph opinion is interesting not only because it's the first post-Bilski opinion dealing with the patentability of process claims under 35 U.S.C. 101, but also because it is completely silent on an interesting post-Bilski issue that was discussed extensively during oral agument.

<div style="clear:both;margin-top:100px;">
Related posts:<ol><li><a href='http://promotetheprogress.com/inconsistency-between-patent-office-and-federal-circuit-applications-of-bilski/1080/' rel='bookmark' title='Permanent Link: Inconsistency between Patent Office and Federal Circuit applications of Bilski?'>Inconsistency between Patent Office and Federal Circuit applications of Bilski?</a></li></ol></div>]]></description>
			<content:encoded><![CDATA[<p>One paragraph opinions from the Court of Appeals for the Federal Circuit are, generally speaking, not all that interesting. The court&#8217;s opinion in <a title="Opinion of the Court of Appeals for the Federal Circuit in Classen Immunotherapies v. Biogen IDEC" href="http://promotetheprogress.com/caselaw/opinions/classen-immunotherapies-v-biogen-idec/61634.html"><em>Classen Immunotherapies v. Biogen IDEC</em></a>, decided the week before Christmas, breaks this general rule, though.  The one paragraph opinion is interesting not only because it&#8217;s the first post-Bilski opinion dealing with the patentability of process claims under 35 U.S.C. 101, but also because it is completely silent on an interesting post-<em>Bilski</em> issue that was discussed extensively during oral agument.</p>
<p>	Understanding the timing of these two cases is important. On October 30, 2008, the court announced its much-anticipated decision in <em>In re Bilski</em> in which the court adopted the machine-or-transformation test for patentability of processes under 35 U.S.C. 101. The court heard oral arguments for <em>Classen</em> <span style="text-decoration: underline;">after</span> oral argument for <em>Bilski</em> but <span style="text-decoration: underline;">before</span> publication of the <em>Bilski</em> opinion. This timing means that members of the <em>Classen</em> panel were likely debating the <em>Bilski</em> issue and/or reviewing the <em>Bilski</em> opinion at the time of the <em>Classen</em> oral argument (The court sat en banc for <em>Bilski</em>).</p>
<p>	Indeed, <a title="Notes on oral arguments for Classen Immunotherapies v. Biogen IDEC at the Court of Appeals for the Federal Circuit" href="http://promotetheprogress.com/caselaw/audio/classen-immunotherapies-v-biogen-idec/61634.html">listening to the <em>Classen</em> oral argument</a> clearly shows that Judge Moore was intensely interested in the patentability of mental processes at the time. She initiated a discussion on the issue by asking counsel for the patentee to ignore the non-mental immunizing step of the claim at issue (&#8220;yes, clearly you&#8217;re absolutely right&#8230;these are not exclusively mental process claims.&#8221;). Counsel entered into an academic discussion with Judge Moore only reluctantly and eventually offered an interesting perspective on why such claims should be patentable (just because you can&#8217;t enforce a patent doesn&#8217;t mean you should be prevented from getting the patent).</p>
<p>	Then, after this fascinating discussion, the court issued <a title="Opinion of the Court of Appeals for the Federal Circuit in Classen Immunotherapies v. Biogen IDEC" href="http://promotetheprogress.com/caselaw/opinions/classen-immunotherapies-v-biogen-idec/61634.html">its one paragraph opinion</a> that summarily dismisses the claims as unpatentable. To support this holding, the court pointed only to <em>Bilski</em>. This would be unremarkable, of course, if the claims at issue in <em>Classen</em> were pure mental process claims. But, as is clear from the oral argument, the claims included a non-mental step (immunizing). Indeed, as mentioned above, Judge Moore had to hypothetically remove this step from the claim in order to entice counsel into the patentability discussion in the first place.</p>
<p>	So what became of the non-mental immunizing step? We really have no idea. But, considering the lack of discussion in the <em>Classen</em> opinion and its non-precedential status, we know that an open question exists as to whether a non-mental step (particularly, a <span style="text-decoration: underline;">known</span> non-mental step) in a process claim that can otherwise be performed mentally is sufficient to confer patentability.</p>
<p>	How&#8217;s that for an interesting one paragraph opinion?</p>
<div class="tweetmeme_button" style="float: left; margin: 3px 10px 30px 0px;"><a href="http://api.tweetmeme.com/share?url=http%3A%2F%2Fpromotetheprogress.com%2Fafter-bilski-what-about-mental-process-claims-that-include-a-known-non-mental-step%2F854%2F"><img src="http://api.tweetmeme.com/imagebutton.gif?url=http%3A%2F%2Fpromotetheprogress.com%2Fafter-bilski-what-about-mental-process-claims-that-include-a-known-non-mental-step%2F854%2F" height="61" width="51" /></a></div>

<div style="clear:both;margin-top:100px;"><p>Related posts:</p><ol><li><a href='http://promotetheprogress.com/inconsistency-between-patent-office-and-federal-circuit-applications-of-bilski/1080/' rel='bookmark' title='Permanent Link: Inconsistency between Patent Office and Federal Circuit applications of Bilski?'>Inconsistency between Patent Office and Federal Circuit applications of Bilski?</a></li></ol></div>]]></content:encoded>
			<wfw:commentRss>http://promotetheprogress.com/after-bilski-what-about-mental-process-claims-that-include-a-known-non-mental-step/854/feed/</wfw:commentRss>
		<slash:comments>3</slash:comments>
		</item>
	</channel>
</rss>
